If you live in Nebraska and are researching compounded GLP-1 medications for weight management, this page is meant to save you the tab-hopping. It covers how telehealth access works in the state, the Nebraska rules that actually matter, what compounded semaglutide and tirzepatide cost from providers that publish their prices, and answers to the questions Nebraskans ask most often.
One disclosure before we start: this site is operated by Gentle Health, a telehealth provider of compounded GLP-1 medications. Gentle Health appears in the comparison table below on the same terms as every other provider, and we link to competitors’ own pages so you can check each price yourself.
How compounded GLP-1 access works in Nebraska
Nebraska is a large state with a small number of metro areas, and most of its 93 counties have no obesity-medicine specialist at all. That is the gap telehealth fills. Instead of driving to Omaha or Lincoln for an appointment, a patient completes the entire process from home, whether home is Scottsbluff, Norfolk, Kearney, or a ranch outside Valentine.
Here is what the process looks like at Gentle Health:
- Online health intake. You answer a detailed medical questionnaire covering your health history, current medications, and weight-management goals.
- Medical evaluation. Your intake is reviewed by James Simmons, MD, who is licensed to practice in Nebraska through the Interstate Medical Licensure Compact (license CP2520, state board record), a licensing pathway Nebraska joined in 2017. Dr. Simmons evaluates whether GLP-1 therapy is medically appropriate for you. Not everyone qualifies, and treatment is always subject to medical evaluation.
- Prescription and shipping. If Dr. Simmons determines treatment is appropriate, he writes a prescription for compounded semaglutide or compounded tirzepatide. A licensed compounding pharmacy prepares the medication for you specifically and ships it to your Nebraska address.
- Ongoing care. Dosing is adjusted over time based on how you respond, and you can message Dr. Simmons with questions between check-ins.
The single-physician model is a deliberate choice. At many national telehealth platforms, you are assigned whichever clinician is available in your state that day. At Gentle Health, care in Nebraska is provided by Dr. Simmons, the same physician who treats Gentle Health patients in every state we serve. If you have a question in month four, you are asking the person who evaluated you in month one.
Eligibility details and license verification for Nebraska are on our Nebraska page. How the initial review itself works, asynchronous or by scheduled video, varies by state; the full breakdown is here.
Nebraska rules worth knowing
Nebraska is, on the whole, a straightforward state for telehealth. A few specifics are worth understanding before you sign up with any provider.
A provider-patient relationship can be established online. Under Neb. Rev. Stat. 38-1,143, any credential holder under Nebraska’s Uniform Credentialing Act may establish a provider-patient relationship through telehealth, and may prescribe medication through telehealth if authorized to prescribe under state and federal law. In plain terms: Nebraska does not require an in-person visit before a physician can evaluate you and, where appropriate, prescribe a non-controlled medication like a GLP-1. The Center for Connected Health Policy’s Nebraska profile, updated March 2026, summarizes these provisions.
You must receive written information before your first telehealth visit. The Nebraska Telehealth Act (Neb. Rev. Stat. 71-8505) requires practitioners to provide patients with written information before an initial telehealth consultation, including what to expect from telehealth care. A legitimate provider will handle this as part of onboarding; if one does not, treat it as a yellow flag.
Out-of-state pharmacies need a Nebraska license to ship here. Any pharmacy located outside Nebraska must hold a Nebraska out-of-state mail service pharmacy license before shipping dispensed prescription drugs to Nebraska residents, and must employ at least one Nebraska-licensed pharmacist responsible for compliance. This is a reasonable thing to ask any telehealth provider about: is the pharmacy filling my prescription licensed to ship into Nebraska?
On compounded GLP-1s specifically, federal rules do most of the talking. We could not locate GLP-1-specific public guidance from the Nebraska Board of Pharmacy; the operative framework is federal. After the FDA declared the semaglutide and tirzepatide shortages resolved (December 2024 for tirzepatide, February 2025 for semaglutide), it clarified its policies for compounders: pharmacies may not compound what amounts to a copy of a commercially available drug. Compounding remains lawful when a prescriber determines that a compounded preparation meets a specific patient’s clinical needs in a way the commercial product does not, prepared pursuant to a patient-specific prescription. Nebraska Medicine, the Omaha-based academic health system, published a provider explainer on what the end of shortage-era compounding means in practice. The practical takeaway for Nebraska patients: compounded GLP-1s are still available, but only through the patient-specific pathway, which is exactly why a real medical evaluation matters.
Physician licensing crosses state lines through the Compact. Nebraska has been a member of the Interstate Medical Licensure Compact since 2017 (codified at Neb. Rev. Stat. 38-3602). The Compact is a streamlined pathway through which a physician licensed in one member state can obtain a full, unrestricted license in another. A physician treating Nebraska patients through the Compact holds an actual Nebraska license, subject to Nebraska’s medical board, not a workaround.
Compounded semaglutide in Nebraska
Semaglutide is a GLP-1 receptor agonist: it mimics a naturally occurring hormone that helps regulate appetite and blood sugar. Compounded semaglutide is a version of the medication prepared by a licensed compounding pharmacy pursuant to a prescription written for an individually identified patient. Compounded medications are not FDA-approved, and they are not the branded, FDA-approved semaglutide products; they are different products, prepared under state pharmacy licensure and federal compounding law rather than through the FDA’s approval process.
Why do Nebraskans choose the compounded route? Cost, mostly. Branded GLP-1 medications commonly run over $1,000 per month at list price, and insurance coverage for weight management remains inconsistent across Nebraska employers and plans. Compounded semaglutide typically costs a fraction of that, and pricing is usually cash-pay and dose-tiered, which makes budgeting predictable.
Gentle Health’s pricing for Nebraska patients:
- Oral compounded semaglutide: starting at $112 per month. A daily formulation for patients who prefer not to use injections.
- Injectable compounded semaglutide: starting at $135 per month. A once-weekly subcutaneous injection, the more common format.
Both prices are dose-tiered cash-pay rates. They include the medical evaluation and ongoing care from Dr. Simmons, and they do not change as your dose is titrated. Gentle Health does not accept insurance, and there are no membership fees layered on top.
As the comparison table below shows, published prices for compounded semaglutide from other providers serving Nebraska start at about $149 per month, sometimes with consult fees or first-month promotional rates that revert to a higher ongoing price. When comparing, always ask what the ongoing monthly price is after any introductory period, and whether consults cost extra.
Compounded tirzepatide in Nebraska
Tirzepatide works on two hormone receptors, GLP-1 and GIP, which is why you will sometimes see it described as a dual agonist. Like compounded semaglutide, compounded tirzepatide is prepared by a licensed compounding pharmacy for an individually identified patient under a prescription, and it is not an FDA-approved product.
Whether semaglutide or tirzepatide is the better fit for you is a medical judgment, not a menu choice. At Gentle Health, that judgment is made by Dr. Simmons based on your health history, your medications, and how you respond to treatment over time. Some patients start on one and later switch to the other; that, too, is a clinical decision made with your physician.
Gentle Health’s pricing for Nebraska patients:
- Injectable compounded tirzepatide: starting at $169 per month, cash-pay and dose-tiered, with evaluation and ongoing care included. The monthly price changes if the prescribed dose moves into a different tier.
Published tirzepatide prices from other providers serving Nebraska currently range from about $233 to $299 or more per month, and some providers list ongoing rates well above their advertised starter rates. The same comparison advice applies: confirm the post-introductory monthly price, confirm what is included, and confirm the pharmacy can legally ship to a Nebraska address.
Provider options in Nebraska: comparison table
Methodology: prices below were taken from each provider’s public website on July 27, 2026; where a provider does not publish pricing, we write “See site” rather than guessing. Rows are alphabetical. Gentle Health operates this site and is included on the same terms.
| Provider | Care model | Compounded semaglutide (cash/mo) | Compounded tirzepatide (cash/mo) | Serves Nebraska | Insurance | Source |
|---|---|---|---|---|---|---|
| Gentle Health | Telehealth; care provided by James Simmons, MD | From $112 (oral), From $135 (injectable) | From $169 (injectable) | Yes | No; cash-pay | gentle.health (verified 2026-07-30) |
| Henry Meds | Telehealth; NP/PA care team | See site (site FAQ: GLP-1 plans from $179/mo) | See site | Not stated; see site | No; cash-pay | henrymeds.com (verified 2026-07-30) |
| OrderlyMeds | Telehealth; 50-state provider network | $149 ($74/mo starter offer) | $299 ($149/mo starter offer) | Yes (per site, all 50 states) | No; cash-pay | orderlymeds.com (verified 2026-07-27) |
| Remedy Meds | Telehealth; clinician network | See site | See site | Not stated; see site | No; cash-pay (HSA/FSA accepted per site) | remedymeds.com (verified 2026-07-27) |
| ZYP Medical | Telehealth plus in-person clinic in Gretna, NE; FNP-led | $150 (starter-plan average; consult fee separate) | $233 injectable, $250 oral tablet (starter-plan average; consult fee separate) | Yes (NE, IA, SD, MN, KS, CO, AZ) | No; cash-pay | zypmed.com (verified 2026-07-27) |
A few notes on reading the table. Starter and promotional rates are listed where a provider leads with them, but the ongoing rate is the number to budget around. ZYP Medical charges a separate consult fee ($29.99 to $50 depending on visit type, per its site) before its monthly medication pricing begins. Henry Meds does not publish clear standard per-medication prices on its public pages. Gentle Health’s prices are dose-tiered monthly rates with the evaluation included. We have not evaluated any competitor’s clinical care and make no claims about it; the table reports published prices and stated care models only.
For a year-long, all-fees-included view of how the major programs price out, see our full comparison of what GLP-1 programs actually cost.
Frequently asked questions
Is compounded GLP-1 medication legal in Nebraska?
Yes, within limits. Nebraska law permits telehealth prescribing of non-controlled medications, and licensed compounding pharmacies may prepare patient-specific compounded medications under federal compounding law. Since the FDA declared the national shortages resolved, pharmacies may no longer mass-produce copies of commercially available GLP-1 drugs; compounded versions must be prescribed for an individually identified patient based on that patient’s clinical needs. Compounded medications are not FDA-approved.
Do I need to see a doctor in person in Nebraska first?
No. Under Neb. Rev. Stat. 38-1,143, a provider-patient relationship may be established through telehealth in Nebraska, and a practitioner may prescribe through telehealth if authorized under state and federal law. You should still receive written information about telehealth care before your first visit, as the Nebraska Telehealth Act requires.
Who would actually be treating me at Gentle Health?
James Simmons, MD. He is licensed to practice in Nebraska through the Interstate Medical Licensure Compact, which means he holds a full Nebraska medical license subject to Nebraska’s licensing board. He performs the medical evaluation, decides whether treatment is appropriate, writes the prescription if it is, and manages your care over time.
Does insurance cover compounded GLP-1s in Nebraska?
Generally no. Insurance plans rarely cover compounded medications, and coverage for weight-management medication of any kind varies widely among Nebraska employers and plans. Every provider in the comparison table above, including Gentle Health, operates on a cash-pay basis for compounded GLP-1s. Gentle Health’s dose-tiered monthly rates start at $112 for oral semaglutide, $135 for injectable semaglutide, and $169 for tirzepatide.
I live in rural Nebraska. Does any of this work differently for me?
No, and that is rather the point. The evaluation happens online, follow-ups happen online, and the medication ships to your address, whether that is in Omaha or Cherry County. The one thing worth checking with any provider is that its pharmacy holds a Nebraska out-of-state mail service pharmacy license, which is required before a non-Nebraska pharmacy can ship prescription drugs into the state.
Why do prices differ so much between providers?
Business models differ. Some providers advertise low first-month rates that rise afterward; some charge separate consult or membership fees; some price oral and injectable formats differently. When you compare, use the ongoing monthly price with all fees included. That is the basis on which the table above was assembled, with links to each provider’s page so you can verify the numbers yourself.
What should I ask before starting with any telehealth provider?
Four questions cover most of it. Is the prescriber licensed in Nebraska? Is the pharmacy licensed to ship into Nebraska? What is the ongoing monthly price after any introductory rate, including all fees? And who, specifically, will be managing my care over time? Any provider worth using will answer all four plainly.
Current Gentle Health dose tiers and pricing
Gentle Health pricing depends on the dose tier prescribed by your clinician. Current monthly prices are:
Oral compounded semaglutide
| Tier | Daily dose | Monthly price |
|---|---|---|
| Starting | 2-4 mg/day | $112/mo |
| Medium | >4-8 mg/day | $189/mo |
| High dose | >8-12 mg/day | $258/mo |
Injectable compounded semaglutide
| Tier | Weekly dose | Monthly price |
|---|---|---|
| Starting | 0.24-0.48 mg/wk | $135/mo |
| Medium | >0.48-1.2 mg/wk | $159/mo |
| High dose | >1.2-2.4 mg/wk | $199/mo |
Injectable compounded tirzepatide
| Tier | Weekly dose | Monthly price |
|---|---|---|
| Starting | 2.5-5 mg/wk | $169/mo |
| Medium | >5-10 mg/wk | $219/mo |
| High dose | >10-15 mg/wk | $269/mo |
Medication, the initial review by a licensed clinician, video visits and messaging, and overnight refrigerated shipping are included. There is no separate membership fee, and HSA and FSA cards are accepted. Your clinician determines the appropriate medication and dose; the monthly price changes if the prescribed dose moves into a different tier.
Gentle Health serves patients across a growing multistate footprint through clinicians licensed in each patient’s jurisdiction, including Nebraska.
Reviewed by James Simmons, MD
Compounded medications are not FDA-approved. Treatment subject to medical evaluation.